Vanderbilt researchers have established a new measure of resilience to cognitive impairment in people with asymptomatic Alzheimer’s disease. They essentially flipped the standard approach used by researchers when mining the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, said Timothy Hohman, Ph.D., the lead author of the study published online Nov. 4 in Neurology. Instead of assessing factors linked to cognitive decline, they sought to identify participants who maintained cognitive performance.
Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia. It was known that African-Americans are at a higher risk for Alzheimer’s disease, said the study’s first author, Timothy Hohman, Ph.D., assistant professor of Neurology.
Vanderbilt University Medical Center and Brigham and Women’s Hospital in Boston recently collaborated on a study analysis to determine the effect of a tailored, pharmacist-delivered health literacy intervention on unplanned hospital readmission or emergency department visit following discharge.
Reduction in 30-day readmission rates following hospitalization is a goal at Vanderbilt and hospitals across the country. Each is motivated to keep their readmission rates in check or face receiving less money from Medicare.
The Vanderbilt Memory & Alzheimer's Center would like to announce our May lecturer in our VMAC Guest Lecture Series, Dr. Claudia Kawas, Al and Trish Nichols Chair in Clinical Neuroscience and Professor of Neurobiology & Behavior and Neurology, at the University of California, Irvine. Over the past 25 years, Dr.
The Vanderbilt Memory & Alzheimer's Center would like to announce our February lecturer in our VMAC Guest Lecture Series, Dr. Denise Park, Director of Research of the Center for Vital Longevity, Regents' Research Scholar and professor of behavioral and brain sciences, and Distinguished University Chair in Behavioral and Brain Sciences.